EST64454(1950569-11-5)
- Name: EST64454
- Synonyms:EST64454;EST64454 hydrochloride;EST64454 HCl;pain,Inhibitor,EST 64454,EST64454 hydrochloride,nerve,selective,EST-64454 hydrochloride,Sigma Receptor,EST-64454,oral,inhibit;EST64454 hydrochloride, 10 mM in DMSO
- Molecular Formula:C18H23ClF2N4O2
- Molecular Weight:400.85
- CAS Registry Number:1950569-11-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1949836-86-5/2-(5-Cyclopropyl-3-(thiophen-2-yl)-1H-pyrazol-1-yl)acetonitrile
- 1949836-87-6/(1-(2,3-dihydro-1H-inden-2-yl)piperidin-4-yl)methanol
- 1949836-91-2/(5-methylisoxazol-4-yl)methanamine hydrochloride
- 1949836-92-3/Methyl 2-(2-imino-6-(methylsulfonyl)benzo[d]thiazol-3(2H)-yl)acetate hydrobromide
- 1949836-94-5/4-Chlorocinnoline hydrochloride
- 1949837-63-1/5-Isoxazolecarboxylic acid, 3-(5-amino-2-chloro-4-fluorophenyl)-4,5-dihydro-5-methyl-, ethyl ester
- 1949843-39-3/m-PEG12-NH-C2-acid
- 194988-29-9/Phosphoramidic acid, N,N-dimethyl-, 3-chloro-4-methyl-2-oxo-2H-1-benzopyran-7-yl ethyl ester
- 194991-48-5/2,6-Anhydro-L-glucitol
- 195004-74-1/Pyridine, 1-[bis(2-methyl-2-propenyl)boryl]-3-bromo-1,2-dihydro-2-(2-methyl-2-propenyl)- (9CI)
- 195006-73-6/β-D-Glucopyranose, 6-O-[2-O-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2-propen-1-yl]-β-D-glucopyranosyl]-, 1-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-propenoate] 2-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate]
- 195006-74-7/β-D-Glucopyranose, 6-O-β-D-glucopyranosyl-, 1-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-propenoate] 2-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate]
- 195006-75-8/β-D-Glucopyranose, 6-O-β-D-glucopyranosyl-, 1,2-bis[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-propenoate]
- 195008-76-5/2-[2,2-bis(2-prop-2-enoyloxyethoxymethyl)butoxy]ethyl 3-(dibutylamino)propanoate
- 1950256-93-5/5-Pyrimidinecarbonitrile, 1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-6-[(2-pyrrolidinylmethyl)amino]-
- 195051-22-0/1H-Naphtho[2,3-c]pyran-3-acetic acid, 4a,4'a-thiobis[3,4,4a,5,10,10a-hexahydro-9,10a-dihydroxy-1-methyl-5,10-dioxo-, dimethyl ester, (1R,1'R,3R,3'R,4aR,4'aR,10aS,10'aS)-
- 195051-23-1/1H-Naphtho[2,3-c]pyran-3-acetic acid, 4a-[[1,3,4,5,10,10a-hexahydro-9,10a-dihydroxy-3-(2-hydroxyethyl)-1-methyl-5,10-dioxo-4aH-naphtho[2,3-c]pyran-4a-yl]thio]-3,4,4a,5,10,10a-hexahydro-9,10a-dihydroxy-1-methyl-5,10-dioxo-, methyl ester, (-)-
- 195052-09-6/Cyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, 2-[[6-[(6-acetyl-3,6,7,8-tetrahydro-5-hydroxy-4-methoxybenzo[1,2-b:4,3-b']dipyrrol-2-yl)carbonyl]-3,6,7,8-tetrahydro-5-hydroxy-4-methoxybenzo[1,2-b:4,3-b']dipyrrol-2-yl]carbonyl]-1,2,8,8a-tetrahydro-7-methyl-
- 1950566-51-4/5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-amino-3-(chloromethyl)-8-oxo-, (3-chloro-4-methoxyphenyl)methyl ester, (6R,7R)-
- 1950569-11-5/EST64454
- 1950574-55-6/(3,3-dimethylcyclobutyl)boronic acid
- 195057-79-5/1,4:5,8-Dimethanonaphthalene-2-carboxylic acid, 1,2,3,4,4a,5,8,8a-octahydro-, 1,1-dimethylethyl ester
- 1950579-53-9/β-D-Glucopyranosiduronic acid, (2β,3β)-28-(β-D-glucopyranosyloxy)-2-hydroxy-28-oxoolean-12-en-3-yl 3-O-β-D-xylopyranosyl-
- 1950581-97-1/β-D-Glucopyranosiduronic acid, (2β,3β,4α)-28-(β-D-glucopyranosyloxy)-2,23-dihydroxy-28-oxoolean-12-en-3-yl 3-O-β-D-xylopyranosyl-
- 1950586-56-7/1-Pyrenyl Potassium Sulfate
- 1950587-17-3/1-amino-N-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]Cyclobutanecarboxamide
- 1950587-19-5/Benzoic acid, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-, methyl ester
- 1950587-20-8/4-((1-((6-cyano-5-(trifluoromethyl)pyridin-3-yl)carbamoyl)cyclobutyl)amino)-2-fluoro-N-methylbenzamide
- 1950587-21-9/2-Pyridinecarbonitrile, 5-isocyanato-3-(trifluoromethyl)-
- 1950607-84-7/Anthracene, 1-bromo-9,10-dihydro-9,9,10,10-tetramethyl-